Actively Recruiting
Randomized Trial to Assess Safety and Immune Response of Combined Diphtheria, Tetanus, Pertussis, and Sabin Poliomyelitis Vaccine in Children Aged 2 Months to 6 Years
Led by Institute of Medical Biology, Chinese Academy of Medical Sciences · Updated on 2026-10-23
380
Participants Needed
3
Research Sites
58 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a randomized, positive-controlled phase III clinical trial to evaluate the safety and preliminary immune response of a combined vaccine for Diphtheria, Tetanus, Acellular Component Pertussis, and Sabin Inactivated Poliomyelitis. This study involves children aged 2 months to 6 years and aims to assess how well the vaccine works and its safety in these young participants. The trial compares three vaccine groups one receiving the experimental combined vaccine, another receiving a Diphtheria, Tetanus, and Acellular Component Pertussis vaccine, and a third group receiving the combined vaccine plus an inactivated poliomyelitis vaccine. Dosages are 0.5 mL per dose with various immunization schedules depending on age, including basic immunization doses during infancy and a booster dose between 18 and 24 months of age. Participants will be involved in scheduled vaccinations and monitored for adverse events immediately after vaccination and for up to 30 days after each dose. Researchers will measure immune responses 30 days after primary and booster immunizations, checking antibody rates and concentrations. Safety monitoring continues for up to 12 months after the last vaccination, with regular visits and assessments to track any side effects or immune response changes throughout the study.
CONDITIONS
Brief Title
A Phase I/II Clinical Trial of the Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine Adsorbed
Research Team
J
Jingsi Yang
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here